Use of cell-free circulating RNA and expression of PD-L1 and HER2 in plasma to monitor and predict clinical response in metastatic breast cancer patients

被引：0
|
作者：
Castrellon, Aurelio B.
Velez, Michel
Raez, Luis E.
Danenberg, Kathleen
Rabizadeh, Shahrooz
Usher, Joshua
Jaimes, Yolanda
Hunis, Brian
Bittencourt, Ana C.
Milillo, Adriana
Blaya, Marcelo
Habaue, Cheryl
Danenberg, Peter V.
机构：
[1] Mem Canc Inst, Hollywood, FL USA
[2] Liquid Genom Inc, Culver City, CA USA
[3] NantOmics, Culver City, CA USA
[4] Univ Southern Calif, Keck Sch Med, Los Angeles, CA USA
来源：
CANCER RESEARCH | 2018年 / 78卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2-02-16
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Use of cell-free circulating RNA (cfRNA) levels in plasma and expression of HER2 and PD-L1 to monitor disease status in metastatic cancer patients.
    Raez, Luis E.
    Danenberg, Kathleen
    Castrellon, Aurelio Bartolome
    Velez, Michel
    Usher, Joshua L.
    Rabizadeh, Shahrooz
    Jaimes, Yolanda S.
    Hunis, Brian
    Habaue, Cheryl
    Danenberg, Peter
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [2] Use of Cell-Free Circulating RNA (cfRNA) Expression of PD-L1 and ERCC1 in Plasma to Monitor Response to Therapy in NSCLC
    Raez, L.
    Danenberg, K.
    Castrellon, A.
    Rabizadeh, S.
    Usher, J.
    Jaimes, Y.
    Hunis, B.
    Dietrich, M.
    Habaue, C.
    Danenberg, P.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2089 - S2090
  • [3] Correlation of cell-free circulating DNA, RNA, and PD-L1 from plasma with clinical response in patients with metastatic lung and breast cancers.
    Raez, Luis E.
    Danenberg, Kathleen
    Castrellon, Aurelio Bartolome
    Usher, Joshua L.
    Jaimes, Yolanda S.
    Hunis, Brian
    Velez, Michel E.
    Habaue, Cheryl
    Danenberg, Peter
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [4] PD-L1 and HER2 expression in gastric cancer (GC) patients (pts) using cell-free RNA (cfRNA).
    Shen, James Yu Chang
    Usher, Joshua
    Samberg, David
    Ishiba, Toshiyuki
    Danenberg, Kathleen
    Lenz, Heinz-Josef
    Barzi, Afsaneh
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [5] Plasma Cell-Free RNA PD-L1 Expression and Clinical Outcomes With Immunotherapy
    Jayananda, S.
    Muzaffar, M.
    Namireddy, P.
    Sharma, N.
    Walker, P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 112 (02): : E9 - E9
  • [6] A Systematic Review of the Use of Circulating Cell-Free DNA Dynamics to Monitor Response to Treatment in Metastatic Breast Cancer Patients
    Jongbloed, Elisabeth M.
    Deger, Teoman
    Sleijfer, Stefan
    Martens, John W. M.
    Jager, Agnes
    Wilting, Saskia M.
    CANCERS, 2021, 13 (08)
  • [7] PD-L1 expression on circulating tumor cells and platelets in patients with metastatic breast cancer
    Darga, Elizabeth P.
    Dolce, Emily M.
    Fang, Fang
    Kidwell, Kelley M.
    Gersch, Christina L.
    Kregel, Steven
    Thomas, Dafydd G.
    Gill, Anoop
    Brown, Martha E.
    Gross, Steven
    Connelly, Mark
    Holinstat, Michael
    Cobain, Erin F.
    Rae, James M.
    Hayes, Daniel F.
    Paoletti, Costanza
    PLOS ONE, 2021, 16 (11):
  • [8] PD-L1 expression on circulating monocytes in patients with breast cancer
    Nagano, M.
    Saito, K.
    Kozuka, Y.
    Shibusawa, M.
    Imai, N.
    Noro, A.
    Kageyama, Y.
    Mizuno, T.
    Ogawa, T.
    Katayama, N.
    ANNALS OF ONCOLOGY, 2018, 29
  • [9] Plasma cell-free RNA PD-L1 or Tissue PD-L1 Protein Expression and Immunotherapy Outcomes in Advanced Non-Small Cell Lung Cancer
    Walker, Paul R.
    Jayananda, Sriraksha
    Pasli, Melisa
    Muzaffarl, Mahvish
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (07) : E17 - E17
  • [10] Clinical Relevance of Serum HER2 and Circulating Tumor Cell Detection in Metastatic Breast Cancer Patients
    Banys-Paluchowski, Malgorzata
    Witzel, Isabell
    Riethdorf, Sabine
    Rack, Brigitte
    Janni, Wolfgang
    Fasching, Peter Andreas
    Solomayer, Erich-Franz
    Aktas, Bahriye
    Kasimir-Bauer, Sabine
    Pantel, Klaus
    Fehm, Tanja
    Mueller, Volkmar
    ANTICANCER RESEARCH, 2017, 37 (06) : 3117 - 3128
12345